XLO · Xilio Therapeutics, Inc. · Documents
Market Cap
$44.47M
Shares
5.78M
Volume · Oct 28
7004
Avg daily vol (3M)
12.97K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2022-06-16 | 2022-06-15 | |
| 8-K | — | 2022-06-13 | 2022-06-09 | |
| 8-K | — | 2022-05-12 | — | |
| 10-Q | — | 2022-05-12 | 2022-03-31 | |
| DEF 14A | — | 2022-04-26 | 2022-06-09 | |
| DEFA14A | — | 2022-04-26 | — | |
| 10-K | — | 2022-03-01 | 2021-12-31 | |
| 8-K | — | 2022-03-01 | — | |
| 8-K | — | 2022-02-04 | 2022-02-03 | |
| 8-K | — | 2022-01-06 | 2022-01-04 | |
| 8-K | — | 2021-12-02 | — | |
| 10-Q | — | 2021-12-02 | 2021-09-30 | |
| 8-K | — | 2021-10-26 | — | |
| S-1/A | — | 2021-10-20 | — | |
| S-1/A | — | 2021-10-18 | — | |
| S-1 | — | 2021-10-01 | — |
Showing 101–116 of 116 filings